Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Olga Polyanskaya"'
Autor:
Nikita Razuvanov, Yaroslav Listratov, Aleksey Zakharov, Olga Polyanskaya, Natalia Pyatnitskaya
Publikováno v:
Heat Transfer Engineering. 44:1208-1220
Autor:
Stéphane de Botton, Pierre Fenaux, Karen W.L. Yee, Christian Récher, Andrew H Wei, Pau Montesinos, David C. Taussig, Arnaud Pigneux, Thorsten Braun, Antonio Curti, Carolyn S Grove, Brian A. Jonas, Asim Khwaja, Ollivier Legrand, Pierre Peterlin, Montserrat Arnan, William Blum, Daniela Cilloni, Devendra K. Hiwase, Joseph G. Jurcic, Jürgen Krauter, Xavier Thomas, Justin M Watts, Jay Yang, Olga Polyanskaya, Julie Brevard, Jennifer Sweeney, Emma Barrett, Jorge Cortes
Publikováno v:
Blood Advances.
Olutasidenib (FT-2102) is a potent, selective, oral, small-molecule inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1). Overall, 153 IDH-1 inhibitor naïve patients with mIDH1R132 relapsed/refractory (R/R) acute myeloid leukemia (AML) received ol
Autor:
Tatiana Kukhta, Vasilina Yauseyenka, Maureen Hatch, Iliya Veyalkin, Kiyohiko Mabuchi, Alexander Rozhko, Rimma Grakovitch, Elizabeth K. Cahoon, Sergey Trofimik, Olga Polyanskaya, Victor Minenko, Evgenia Ostroumova, Vladimir Drozdovitch
Publikováno v:
Health Phys
Thyroid radiation doses were estimated for a cohort of 2,965 Belarusian persons who were exposed in utero and during early life to fallout from the Chernobyl nuclear power plant accident. Prenatal and postnatal doses to the thyroid due to intake of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6028decd9fe3ce9465b9a3bb9ba27965
https://europepmc.org/articles/PMC6931907/
https://europepmc.org/articles/PMC6931907/
Autor:
Montserrat Arnan Sangerman, Eunice S. Wang, Julie Brevard, Pierre Peterlin, Olga Polyanskaya, Thomas Prebet, Olivier Legrand, Antonio Curti, Prapti A. Patel, Andrew H. Wei, Brian A. Jonas, Justin M. Watts, Jorge E. Cortes, Stéphane de Botton, Karen W.L. Yee, Thorsten Braun, Xavier Thomas, Jennifer Sweeney, Ashish Bajel, Christian Recher, Jordi Esteve, Pierre Fenaux, Francesco Lanza, Carolyn S. Grove, Pau Montesinos
Publikováno v:
Blood. 138:698-698
Background: Olutasidenib, a potent, selective, oral, small molecule inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1), has been previously shown, as a single agent, to be well tolerated and induce durable complete remissions in a subset of patie
Autor:
Maureen Hatch, Vasilina Yauseyenka, Tamara I Yeudachkova, Vladimir Drozdovitch, Alina V. Brenner, Alexander Rozhko, Wayne Liu, Lydia B. Zablotska, Tamara I Maskvicheva, Robert J. McConnell, Mark P. Little, Kiyohiko Mabuchi, Eldar Nadyrov, Kamau O. Peters, Victor Minenko, Elizabeth K. Cahoon, Olga Polyanskaya, Ilya Veyalkin
Publikováno v:
The Journal of clinical endocrinology and metabolism, vol 102, iss 7
Cahoon, EK; Nadyrov, EA; Polyanskaya, ON; Yauseyenka, VV; Veyalkin, IV; Yeudachkova, TI; et al.(2017). Risk of Thyroid Nodules in Residents of Belarus Exposed to Chernobyl Fallout as Children and Adolescents. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 102(7), 2207-2217. doi: 10.1210/jc.2016-3842. UCSF: Retrieved from: http://www.escholarship.org/uc/item/7dh4f8rp
Cahoon, EK; Nadyrov, EA; Polyanskaya, ON; Yauseyenka, VV; Veyalkin, IV; Yeudachkova, TI; et al.(2017). Risk of Thyroid Nodules in Residents of Belarus Exposed to Chernobyl Fallout as Children and Adolescents. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 102(7), 2207-2217. doi: 10.1210/jc.2016-3842. UCSF: Retrieved from: http://www.escholarship.org/uc/item/7dh4f8rp
Author(s): Cahoon, Elizabeth K; Nadyrov, Eldar A; Polyanskaya, Olga N; Yauseyenka, Vasilina V; Veyalkin, Ilya V; Yeudachkova, Tamara I; Maskvicheva, Tamara I; Minenko, Victor F; Liu, Wayne; Drozdovitch, Vladimir; Mabuchi, Kiyohiko; Little, Mark P; Za
Autor:
Vasilina Yauseyenka, Mark P. Little, Evgenia Ostroumova, Rimma Grakovitch, Andrey Cheshik, Elizabeth K. Cahoon, Ilya Veyalkin, Olga Polyanskaya, Maureen Hatch, Alexander Rozhko, Victor Minenko, Vladimir Drozdovitch, Alina V. Brenner, Kiyohiko Mabuchi, Tatiana Kukhta, Liliya Starastsenka
Publikováno v:
J Radiol Prot
In April 1986, the Chernobyl nuclear accident resulted in wide-scale contamination of Belarus with significantly elevated levels of radioiodine isotopes, mainly iodine-131 (131I), and long-lived radiocaesium isotopes, mainly caesium-137 (137Cs). Vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aab3e4fbe2bf24567ec4c56e289d932
https://europepmc.org/articles/PMC9425727/
https://europepmc.org/articles/PMC9425727/
Autor:
Jordi Esteve, Pierre Fenaux, Ollivier Legrand, Jorge E. Cortes, Andrew H. Wei, Brian A. Jonas, David Taussig, Hesham Mohamed, Asim Khwaja, Arnaud Pigneux, Carolyn S. Grove, Christian Recher, Karen W.L. Yee, Jennifer Sweeney, Olga Polyanskaya, Thorsten Braun, Pierre Peterlin, Antonio Curti, Stéphane de Botton, Pau Montesinos
Publikováno v:
Journal of Clinical Oncology. 39:7006-7006
7006 Background: Olutasidenib, a potent, selective, oral, small molecule inhibitor of mutant IDH1 (m IDH1), has exhibited favorable tolerability and clinical activity in high-risk AML patients (pts) in a phase 1 trial (Watts, Blood 2019). Here, we pr
Autor:
Lydia B. Zablotska, Evgenia Ostroumova, Olga Polyanskaya, Vasilina Yauseyenka, Semion Polyakov, Eldar Nadyrov, Leonid Levin, Alina V. Brenner, Ilya Veyalkin, Maureen Hatch, Alexander Rozhko, Kiyohiko Mabuchi
Publikováno v:
Environmental Research. 147:44-49
BackgroundWhile an increased risk of thyroid cancer from post-Chernobyl exposure to Iodine-131 (I-131) in children and adolescents has been well-documented, risks of other cancers or leukemia as a result of residence in radioactively contaminated are
Autor:
André Bouville, Sergey Nikonovich, Alina V. Brenner, Mark P. Little, Maureen Hatch, Evgenia Ostroumova, Alexander Rozhko, Irina Savasteeva, Kiyohiko Mabuchi, Eldar Nadyrov, Yuri E. Demidchik, Vladimir Drozdovitch, Olga Polyanskaya, Vassilina Yauseyenka, Alexander Nerovnya, Patrick O'Kane, Viktor Minenko, Lydia B. Zablotska, Robert J. McConnell, Zhihong Gong
Publikováno v:
Cancer. 121:457-466
Author(s): Zablotska, Lydia B; Nadyrov, Eldar A; Rozhko, Alexander V; Gong, Zhihong; Polyanskaya, Olga N; McConnell, Robert J; O'Kane, Patrick; Brenner, Alina V; Little, Mark P; Ostroumova, Evgenia; Bouville, Andre; Drozdovitch, Vladimir; Minenko, Vi
Autor:
Patricia Schroeder, Olga Polyanskaya, Diamantis G. Konstantinidis, Lindsey Wilson, Adam Drake, Theodosia A. Kalfa, Santosh L. Saraf, Marilyn J. Telen, Punam Malik, Lukasz Biernat, Jeremy H. Estepp, Sanjeev Forsyth, Patrick Kelly, Frans A. Kuypers, Maria D. Ribadeneira, Hyon J. Kim
Publikováno v:
Blood. 134:616-616
Background: The hallmark of sickle cell disease (SCD) is hemoglobin S (HbS) polymerization upon deoxygenation, resulting in red blood cell (RBC) sickling, oxidative damage, membrane damage, hemolysis, chronic anemia, vaso-occlusions and inflammation.